Time for better presentation and analysis of adverse events

Affiliations

Comment

Tito Mendoza. Lancet Oncol. 2016 May.

. 2016 May;17(5):553-4.

doi: 10.1016/S1470-2045(16)30056-0. Epub 2016 Apr 12.

¹ Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: tmendoza@mdanderson.org.

No abstract available

Comment on

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254.
Thanarajasingam G, Atherton PJ, Novotny PJ, Loprinzi CL, Sloan JA, Grothey A. Thanarajasingam G, et al. Lancet Oncol. 2016 May;17(5):663-70. doi: 10.1016/S1470-2045(16)00038-3. Epub 2016 Apr 12. Lancet Oncol. 2016. PMID: 27083333 Free PMC article.